Sunshine Biopharma Inc. Depreciation and Amortization
Sunshine Biopharma Inc. (SBFM) reported Depreciation and Amortization of $154.83 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Cash Flow › Operating Activities
us-gaap:DepreciationDepletionAndAmortization · last filed 2026-08-13
- Sunshine Biopharma Inc. depreciation, depletion and amortization for the quarter ending 2026-06-30 was $77.97K, a 7.63% increase year-over-year.
- Sunshine Biopharma Inc. depreciation, depletion and amortization for the quarter ending 2026-03-31 was $76.86K, a 18.62% increase year-over-year.
- Sunshine Biopharma Inc. depreciation, depletion and amortization for the quarter ending 2025-12-31 was $98.58K, a 50.74% increase year-over-year.
- Sunshine Biopharma Inc. depreciation, depletion and amortization for the quarter ending 2025-09-30 was $96.25K, a 48.92% increase year-over-year.
- Sunshine Biopharma Inc. depreciation, depletion and amortization for fiscal 2025 was $332.07K, a 48.56% increase from fiscal 2024.
- Sunshine Biopharma Inc. depreciation, depletion and amortization for fiscal 2024 was $223.53K, a 49.87% increase from fiscal 2023.
- Sunshine Biopharma Inc. depreciation, depletion and amortization for fiscal 2023 was $149.15K.
| Period end | Depreciation, Depletion and Amortization 3 month | Depreciation, Depletion and Amortization 6 month | Depreciation, Depletion and Amortization 6 month as first filed | Depreciation, Depletion and Amortization 9 month | Depreciation, Depletion and Amortization 12 month |
|---|---|---|---|---|---|
| 2026-06-30 | $77.97K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13 | $154.83K 10-Q · filed 2026-08-13 | $253.41K derived: sum of 3 quarters · filed 2026-08-13 | $349.67K derived: sum of 4 quarters · filed 2026-08-13 | |
| 2026-03-31 | $76.86K 10-Q · filed 2026-05-13 | $175.44K derived: sum of 2 quarters · filed 2026-05-13 | $271.69K derived: sum of 3 quarters · filed 2026-05-13 | $344.14K derived: sum of 4 quarters · filed 2026-08-13 | |
| 2025-12-31 | $98.58K derived: 10-K 12 month − 10-Q 9 month · filed 2026-04-03 | $194.83K derived: sum of 2 quarters · filed 2026-04-03 | $267.28K derived: sum of 3 quarters · filed 2026-08-13 | $332.07K 10-K · filed 2026-04-03 | |
| 2025-09-30 | $96.25K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | $168.70K derived: sum of 2 quarters · filed 2026-08-13 | $233.49K 10-Q · filed 2025-11-13 | $298.89K derived: sum of 4 quarters · filed 2026-08-13 | |
| 2025-06-30 | $72.44K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13 | $137.24K 10-Q · filed 2026-08-13 | $137.33K 10-Q · filed 2025-08-12 | $202.63K derived: sum of 3 quarters · filed 2026-08-13 | $267.27K derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-03-31 | $64.79K 10-Q · filed 2026-05-13 | $130.19K derived: sum of 2 quarters · filed 2026-05-13 | $194.83K derived: sum of 3 quarters · filed 2026-05-13 | $245.70K derived: sum of 4 quarters · filed 2026-05-13 | |
| 2024-12-31 | $65.40K derived: 10-K 12 month − 10-Q 9 month · filed 2026-04-03 | $130.03K derived: sum of 2 quarters · filed 2026-04-03 | $180.91K derived: sum of 3 quarters · filed 2026-04-03 | $223.53K 10-K · filed 2026-04-03 | |
| 2024-09-30 | $64.63K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | $115.51K derived: sum of 2 quarters · filed 2025-11-13 | $158.13K 10-Q · filed 2025-11-13 | ||
| 2024-06-30 | $50.88K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-12 | $93.49K 10-Q · filed 2025-08-12 | |||
| 2024-03-31 | $42.62K 10-Q · filed 2025-05-15 | ||||
| 2023-12-31 | $149.15K 10-K · filed 2025-04-01 | ||||
| 2016-09-30 | $14.96K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-14 | $29.93K derived: sum of 2 quarters · filed 2016-11-14 | $45.17K 10-Q · filed 2016-11-14 | ||
| 2016-06-30 | $14.96K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-16 | $30.21K 10-Q · filed 2016-08-16 | |||
| 2016-03-31 | $15.24K 10-Q · filed 2016-05-09 | ||||
| 2015-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-14 | $0.00 derived: sum of 2 quarters · filed 2016-11-14 | $0.00 10-Q · filed 2016-11-14 | ||
| 2015-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-16 | $0.00 10-Q · filed 2016-08-16 | |||
| 2015-03-31 | $0.00 10-Q · filed 2016-05-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aptevo Therapeutics Inc. (APVO) | United States | $0.003B | |
| Alaunos Therapeutics, Inc. (TCRT) | United States | $0.003B | -1.44 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| Onconetix, Inc. (ONCO) | United States | $0.004B | |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| HCW Biologics Inc. (HCWB) | United States | $0.004B | -6.15 |
| REVELATION BIOSCIENCES, INC. (REVB) | United States | $0.004B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B |